Name | tirofiban hydrochloride |
---|---|
Synonyms |
L 700462 MK 383 N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine
N-(butylsulfonyl)- O-[4-(4-piperidinyl)butyl]-L-tyrosine monohydrochloride monohydrate N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]tyrosine hydrochloride hydrate N-(Butylsulfonyl)-O-[4-(piperidin-4-yl)butyl]-L-tyrosine hydrochloride hydrate (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid,hydrate,hydrochloride Tirofiban hydrochloride Tirofiban hydrochloride monohydrate tirofiban hydrochloride anhydrous Tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-, hydrochloride, hydrate (1:1:1) Tirofiban Hydrochloride Hydrate Tirofiban (hydrochloride monohydrate) |
Description | Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonistIC50 value:Target: integrin IIb/IIIa Tirofiban hydrochloride monohydrate blocks platelet aggregation and thrombus formation. Tirofiban is an antithrombotic used in the treatment of unstable angina.Tirofiban, in a concentration-dependent manner reduced platelet aggregation evoked by ADP (IC50 approximately 70 ng/ml), collagen (IC50 approximately 200 ng/ml), and thrombin (IC50 approximately 5,000 ng/ml). |
---|---|
Related Catalog | |
References |
[4]. Valgimigli M, Tebaldi M. Safety evaluation of tirofiban. Expert Opin Drug Saf. 2010 Sep;9(5):801-19. |
Boiling Point | 611.7ºC at 760 mmHg |
---|---|
Melting Point | 135-137ºC |
Molecular Formula | C22H39ClN2O6S |
Molecular Weight | 495.073 |
Flash Point | 323.7ºC |
Exact Mass | 494.221741 |
PSA | 122.34000 |
LogP | 5.48870 |
Storage condition | -20°C Freezer |
Water Solubility | DMSO: >12mg/mL at warmed to 60°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Phrases | 36/37/38 |
Safety Phrases | 26-37-45 |
RIDADR | NONH for all modes of transport |